Cargando…
Evaluation of QTc prolongation and dosage effect with citalopram
INTRODUCTION: Recently, controversy has surrounded a 2011 Food and Drug Administration warning against using citalopram at doses >40 mg/day due to QTc prolonging effects. METHODS: Patients ≥18 years old at the VA North Texas Health Care System were included in this retrospective review if they ha...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
College of Psychiatric & Neurologic Pharmacists
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007721/ https://www.ncbi.nlm.nih.gov/pubmed/29955465 http://dx.doi.org/10.9740/mhc.2016.07.165 |